|
|
Details: |
|
|
Markets a range of infertility treatments and endocrinology products.
|
URL: |
http://www.ferringusa.com/
|
Title: |
Ferring Pharmaceuticals |
Image: |
|
Description: |
Health, Reproductive Health, Infertility, Treatment - Ferring Pharmaceuticals, Inc.. Markets a range of infertility treatments and endocrinology products. |
Similar: |
|
|
|
Related Sites |
|
Perspectives Press (Popularity: ): Infertility and adoption publisher. Free online articles as well as books on infertility treatment, emotional issues, and related family building ...
Dr. Daiter - Infertility Guides (Popularity: ): Articles written by reproductive endocrinologist Eric Daiter, M.D
Infertility Help by Spinal Manual Therapy from Davidson Chiropractic (Popularity: ): An article about alternative treatment after you have availed yourself of all available medical diagnostic procedures. Interesting reading about Dr. ...
Atlanta Reproductive Health Centre (Popularity: ): Provides extensive information about infertility, endometriosis and women's healthcare.
Fertility Journal (Popularity: ): Monthly online journal that addresses new discoveries in human reproduction and assisted reproductive technologies.
Varicocele Specialists (Popularity: ): A national directory of physicians expert in varicocele repair and many FAQs about varicocele.
|
|
Popular Sites |
|
|
Related Press |
|
Great Lakes Pharmaceuticals, Inc., Announces $2.4 Million Equity Financing (Popularity: ): Great Lakes Pharmaceuticals, Inc. announced today the completion of Series A $2.4 million equity financing led by Ohio investment funds ...
Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease (Popularity: ): Iodine has been used as an antimicrobial for the last century. Much has been written about molecular iodine yet many ...
Watson' Launches Generic Kadian(R) (Popularity: ): PARSIPPANY, N.J., Nov. 10, 2011 -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that it has received approval from the ...
Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis (Popularity: ): Cerimon Pharmaceuticals, Inc., announced today it has initiated a Phase II proof-of-concept study of Simulect(R) (basiliximab) for the treatment of ...
DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease (Popularity: ): Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing anti-inflammatory drugs, announced today that after completing its review of safety ...
|
|
Related Articles |
|
|
|